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ABSTRACT
Malassezia pachydermatis is considered an opportunistic pathogen of the outer ear duct in dogs and cats. This
yeast can also be found in the skin, rectum, anal sacks and vagina. Eighty-two samples of this yeast isolated from dogs with the
symptoms of external otitis from the Porto Alegre region were tested for their susceptibility to antifungal agents using the Broth
Microdilution Method. The testing antifungal agents were Ketoconazole, Fluconazole and Itraconazole. Experimental essays
determined that Sabouraud dextrose broth supplemented with 1% Tween 80 was the most appropriate medium for culture, for
a ten-fold dilutions for the inocula, and 48 hours as the interval of readings. The ranges of the Minimal Inhibitory Concentra-
tions (MICs) for the 82 samples were (a) Ketoconazole, from 0.015 to 0.25 mg/mL (mean of 0.08 mg/mL), (b) Fluconazole, from
1 to 32 mg/mL (mean of 9.22 mg/mL), and (c) Itraconazole, from 0.007 to 0.125 mg/mL (mean of 0.05 mg/mL). The isolates of M.
pachydermatis showed an excellent level of susceptibility to antifungal azole agents, with all strains being susceptible to
Itraconazole, and with only 2.4 % and 3.7% being resistant to Fluconazole and Kketoconazole, respectively. The use of the
broth microdilution method allows the assessment of the susceptibility of large numbers of samples from M. pachydermatis
isolates to the most common antifungal agents. The proposed procedure is easy to perform and considerably inexpensive
compared with other existing tests, which makes this a method of choice for laboratorial use. A standardization of procedures
currently used in veterinary mycology laboratories is required. Consistent results among laboratories could greatly benefit the
establishment of proper comparisons between studies on antifungal susceptibility and therapeutic trials.
Key words: Antifungal susceptibility, Malassezia pachydermatis, broth microdilution, otitis, ketoconazole, fluconazole,
itraconazole.
RESUMO
Malassezia pachydermatis é uma levedura, habitante normal e patógena oportunista do conduto auditivo exter-
no de cães e gatos, mas também pode ser encontrada na pele, reto, sacos anais e vagina. Oitenta e duas amostras desta
levedura, isoladas de cães com sintomatologia de otite externa oriundos da região de Porto Alegre foram testadas quanto à
susceptibilidade antifúngica pelo teste de Microdiluição em Caldo. Os antifúngicos utilizados foram cetoconazol, fluconazol
e Itraconazol. Ensaios experimentais indicaram que o Sabouraud dextrose líquido acrescido de 1% Tween 80 era o meio de
cultivo mais adequado, assim como a diluição de 1:10 e o tempo de incubação de 48 horas. A faixa de variação da Concen-
tração Inibitória Mínima (CIM) foi a seguinte: cetoconazol de 0,015 a 0,25 mg/mL (media de 0,08 mg/mL); fluconazol de 1 a 32
mg/mL (média de 9,22 mg/mL) e itraconazol de 0,007 a 0,125 mg/mL (media de 0,05 mg/ml). Os isolados de M. pachydermatis
apresentaram uma excelente sensibilidade aos agentes antifúngicos testados sendo todos sensíveis ao itraconazol, com
apenas 2,4% resistentes ao fluconazol e 3,7% ao cetoconazol. O emprego desta proposta de metodologia de microdiluição
em caldo, permite a avaliação da susceptibilidade in vitro de um grande número de isolados clínicos de M. pachydermatis
aos agentes antifúngicos mais comuns. O fato do protocolo ser de fácil execução, aliado ao baixo custo em relação aos
testes similares, torna esta técnica adequada para a rotina laboratorial. Para que seja possível o estabelecimento de compa-
rações criteriosas entre os resultados dos antifungigramas e avaliações cooperativas de ensaios terapêuticos, existe uma
necessidade imperiosa de uma padronização mínima dos protocolos utilizados em laboratórios de Micologia Veterinária.
Descritores: susceptibilidade antifúngica, Malassezia pachydermatis, microdiluição em caldo, otite externa, cetoconazol,
fluconazol, itraconazol.
76
Eichenberg M.L., Appelt C.E., Berg V., Muschner A.C., Nobre M.O., Matta D., Alves S.H. & Ferreiro L. 2003. Susceptibility of
Malassezia pachydermatis to Azole Antifungal Agents Evaluated by a New Broth... Acta Scientiae Veterinariae. 31: 75-80.
INTRODUCTION
The yeast Malassezia pachydermatis is a
common inhabitant of the ear canal of dogs, cats, and
other animals, but it can also be found in the in the
skin, rectum, anal sacks and vagina. This yeast can
also become an opportunistic pathogen [3,6,14]. An
infectious state caused by the M. pachydermatis
usually parallels or follows a primary established illness
in the animal [2-4,11,13,20,22,23,26,29]. Recently, an
increase in the incidence of canine otitis by M.
pachydermatis has been reported in the region covered
by this study [12,18].
The treatment of yeast infections has been
rather empirical and is most often unsuccessful. In
aggravation, susceptibility tests are seldom performed
[8]. The in vitro susceptibility tests for Malassezia
pachydermatis was first described in 1976 by
Maestrone et al. [19]. In Brazil, Coutinho & Paula
[6,7] described the results of similar test in 1997, utilizing
an expensive and non-standardized method, named
ETEST. Several other studies have reported distinct
procedures and non-standard methods [7,8,15,17,24,
26,31,32]. Clearly, a standardization of procedures
currently used in veterinary mycology laboratories is
still lacking.
The aim of this study was to determine the
susceptibility profile of 82 Malassezia pachydermatis
cultures obtained from the ear canal of dogs and cats
to the common antifungal agents Ketoconazole,
Fluconazole and Itraconazole, using a Broth
Microdilution Method modified from procedures
described by the National Committee for Clinical
Laboratory Standards (NCCLS, USA) [25].
MATERIALS AND METHODS
Isolates and culture conditions: Eighty-two
Malassezia pachydermatis cultures obtained from the
ear canal of dogs and cats were used in this study.
Initially, the samples were isolated on Sabouraud
dextrose agar supplemented with chloramphenicol1
(500 mg/L), following incubation at 35°C during four
to seven days. All cultures were maintained on the
same medium described above, at room temperature,
with subcultures being carried out on a monthly basis.
Prior to the assays, isolates were subcultured twice
on the same medium above, and incubated at 35°C for
48h to ensure purity and optimal growth.
Antifungal agents: Media containing each azole agent
used in these experiments were prepared in stock
solutions. Fluconazole2 and Itraconazole3 were
dissolved in sterile distilled water and in polyethylene
glycol 4004, respectively, to obtain stock solutions
containing 500µg/mL. The stock solution of
Ketoconazole3 was diluted in a hydrochloric acid
solution (0.2N) to a final concentration of 10.000µg/
mL, to be subsequently aliquoted and stored frozen at
-70°C until use.
Assay medium: Based on preliminary studies with
RPMI 16405 and Yeast Nitrogen Base6 media (data
not shown), Sabouraud dextrose broth, supplemented
with 1% Tween 80 [16] was chosen for the assays.
Broth microdilution method: Testing was per-
formed in 96-well round-bottom microtiter plates. Cell
suspensions were prepared in Sabouraud dextrose
supplemented with 1% Tween 80, and inoculum
concentrations were adjusted to approximately 0.5 x
106 to 3.0 x 106 cells/mL. Stock solutions were diluted
with Sabouraud dextrose broth supplemented with 1%
Tween 80. The final antifungal agent concentrations
ranged from 0.125 to 64 µg/mL for Fluconazole, 0.078
to 4.0µg/mL for Itraconazole, and 0.015 to 8.0µg/mL
for Ketoconazole. Volumes of 100µL of each antifun-
gal concentration were dispensed in each well,
following procedures described elsewhere (M27
NCCLS protocol). Plates were frozen until assayed,
when 100µL of the adjusted inoculum were enclosed.
Subsequently, plates were incubated at 35°C, to be
read after 48h. The MICs (minimal inhibitory
concentrations) were defined as the lowest azole
concentration at which there was 50% inhibition of
growth (MIC-50) compared with a drug-free growth
control. A culture of Malassezia pachydermatis with
a known clinical sensibility to Itraconazole treatment
was employed as a control reference.
RESULTS
A total of 246 MICs for the azoles used in this
study were determined from the isolates of Malassezia
pachydermatis obtained from clinical cases of canine
otitis (Table 1). The MICs varied from 0.015 to 0.25
mg/mL (mean of 0.08 mg/mL), 1.0 to 32.0 mg/mL
(mean of 9.22 mg/mL), and 0.007 to 0.125 mg/mL
(mean of 0.05 mg/mL) to Ketoconazole, Fluconazole,
and Itraconazole, respectively. The variation observed
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for the MIC to Ketoconazole was greater than to the
other azoles used in these experiments.
The patterns of susceptibility for the 82 isolates
of M. pachydermatis, considering the MIC values (in
mg/mL) for Ketoconazole (MIC-50 ≤ 0.06 and MIC-90
≤ 0.125), Fluconazole (MIC-50 ≤ 8 and MIC-90 ≤ 16),
and Itraconazole (MIC-50 ≤ 0.06 and MIC-90 ≤ 0.125),
are presented in Table 2. Overall, for the range of azole
concentrations used in the susceptibility study, a very low
frequency of resistance was observed in the isolates, with
all samples being susceptible to Itraconazole.
DISCUSSION
A better understanding of the fungal suscepti-
bility profiles to antifungal agents is essential for thera-
peutics, providing epidemiological elements to unravel
the reality of mycotic infections.
After intensive investigations by research
groups [5,9,10,21,27,28,30,31], in vitro susceptibility
tests have been recently standardized (NCCLS M27-
A document) [25] for Candida spp. and Cryptococ-
cus neoformans, with some still being currently un-
derway. However, the M27-A technique should not
be readily applied to Malassezia pachydermatis, since
this yeast has distinct biochemical demands than former
species. Due to its excellent growth pattern demon-
strated in preliminary studies [33], Sabouraud dextrose
broth supplemented with 1% Tween 80, was chosen
as the assay medium to be used in these experiments.
The inoculum concentrations recommended by
the M27-A document for Candida sp. and Crypto-
coccus neoformans did not confer an adequate patho-
gen growth in culture when applied for Malassezia
pachydermatis. An optimal growth pattern was ob-
tained only after a minimum of 100-fold increase in
cell counts (0.5-3.0 x 106 cfu/mL).
The MIC patterns observed in this study dis-
played an acceptable profile if confronted with assays
carried out with those described for Candida sp. and
Cryptococcus neoformans. Based on the results ob-
tained, it appears that important variables such as
medium, inoculum concentrations, pH, and tempera-
ture and time of incubation were adequately selected
for the execution of these experiments.
The interpretation of the observed MIC val-
ues also requires caution because the classification as
susceptible, susceptible-dose depending (SDD), or re-
sistant, as recommended by the M27-A document,
applies specifically to Candida sp. and Cryptococ-
cus neoformans. After adapting this guideline to
Malassezia pachydermatis, the results showed 28
(34.1%) SDD to Fluconazole, 3 (3.7%) resistant to
Ketoconazole, with all isolates being susceptible to
Itraconazole. The significance of these findings, how-
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Further studies on Malassezia pachyder-
matis, as also valid for others species of importance in
veterinary mycology, are still required for the develop-
ment of standard methodologies that could be useful
for comparison studies among MICs. Recently, mo-
lecular studies on clinical M. pachydermatis isolates
from dogs and cats have demonstrated the existence
of some genetic diversity, with strains being classified
in subgroups named A, B, C and D [1]. The epidemio-
logical implications of this classification regarding strain
virulence, clinical presentation and susceptibility to
antifungal agents are still unknown. Studies proposed
to approach these questions must be encouraged.
Finally, it must be emphasized that the meth-
odology employed in this study is easy to perform, has
a very low cost, and could be readily adopted by vet-
erinary laboratories currently investigating clinical and
biological features of Malassezia pachydermatis.
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